Testing effectiveness (Phase 2)Study completedNCT04188964
What this trial is testing
Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of Age
Who this might be right for
X-linked Hypophosphatemia (XLH)
Kyowa Kirin Pharmaceutical Development Ltd 16